This compound is primarily researched for its potential in bone regeneration and osteoporosis treatment. It works by inhibiting the sclerostin protein, which typically suppresses bone formation. By blocking sclerostin, it promotes bone growth and increases bone density. This makes it a promising candidate for developing therapies to treat bone-related disorders, particularly in cases where bone healing is impaired. Additionally, it has been studied in the context of enhancing fracture repair and improving outcomes in orthopedic surgeries. Its application could extend to conditions like osteogenesis imperfecta and other skeletal abnormalities.